A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

NCT05610280 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1478

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia
Cardiovascular Diseases
Atherosclerosis

Interventions

DRUG: Olezarsen
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.